Allergy and Immunology · Las Cruces, NM
NPI
1568414985
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3800 E Lohman Ave Ste A
Las Cruces, NM, 88011
Phone (575) 522-6500
Groups this clinician bills Medicare through
Medicare paid, 2024
$109K
6,610 services
Medicare patients, 2024
285
Average age 74
Drug cost, 2024
$872K
2,753 prescriptions
Company payments, 2025
$37K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael R Rupp was code 95165 (treatment - miscellaneous), 3,345 times for 65 patients. In total Michael R Rupp billed 6,610 services in 15 codes, and Medicare paid $109K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 3,345 | 65 | $10.31 | $34K |
| 95117 Treatment - Miscellaneous | Office | 2,106 | 61 | $8.17 | $17K |
| 99214 Office E&M - Established | Office | 454 | 262 | $85.76 | $39K |
| 94375 Pulmonary Function Testing | Office | 157 | 91 | $26.00 | $4,083 |
| 95012 Pulmonary | Office | 145 | 86 | $12.52 | $1,815 |
| 99457 E&M - Miscellaneous | Office | 98 | 13 | $35.00 | $3,430 |
| 99454 E&M - Miscellaneous | Office | 67 | 11 | $32.28 | $2,162 |
| 99213 Office E&M - Established | Office | 41 | 32 | $56.78 | $2,328 |
| 99458 E&M - Miscellaneous | Office | 24 | 12 | $26.97 | $647 |
| 99205 Office E&M - New | Office | 12 | 12 | $138.72 | $1,665 |
By year: 2022 $118K for 7,214 services; 2023 $107K for 6,680 services; 2024 $109K for 6,610 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael R Rupp prescribed most often to Medicare patients was Azelastine Hcl, with 775 prescriptions and refills. In total Michael R Rupp wrote 2,753 Medicare prescriptions that cost $872K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 775 | 1,365 | 214 | $31K |
| Montelukast Sodium Generic | 408 | 940 | 104 | $5,620 |
| Ipratropium Bromide Generic | 265 | 445 | 113 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 169 | 244 | 28 | $153K |
| Fluticasone Propionate Generic | 166 | 336 | 56 | $3,512 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 108 | 122 | 70 | $2,422 |
| Arnuity Ellipta Fluticasone Furoate | 88 | 133 | 18 | $33K |
| Symbicort Budesonide/Formoterol Fumarate | 65 | 139 | 16 | $32K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 65 | 106 | 15 | $13K |
| Breo Ellipta Fluticasone/Vilanterol | 59 | 95 | 14 | $37K |
| Famotidine Generic | 54 | 84 | 13 | $952 |
| Epinephrine Generic | 36 | 36 | 33 | $6,781 |
| Spiriva Respimat Tiotropium Bromide | 28 | 46 | Under 11 | $23K |
| Esomeprazole Magnesium Generic | 27 | 35 | Under 11 | $303 |
| Pantoprazole Sodium Generic | 27 | 62 | Under 11 | $235 |
Brand drugs: 712 claims; generic drugs: 2,041 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael R Rupp $37K ($37K in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $35K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 41 | $35K |
| GlaxoSmithKline, LLC. GSK | 13 | $409 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 5 | $263 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $103 |
| Genzyme Corporation SNY | 5 | $95.79 |
| CSL Behring CSL.AX | 4 | $93.52 |
| Incyte Corporation INCY | 2 | $92.46 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $51.44 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $46.83 |
| Verona Pharma, Inc. VRNA | 2 | $37.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.